Pharma.Aero inks MoU with IATA to improve quality of pharma handling
Industry body Pharma.Aero signed a Memorandum Of Understanding (MOU) with IATA during the World Cargo Symposium of IATA in Dallas.
March 22, 2018: Industry body Pharma.Aero signed a Memorandum Of Understanding (MOU) with IATA during the World Cargo Symposium of IATA in Dallas.
Nathan De Valck, chairman of Pharma.Aero said, “Formalising the partnership with IATA is an important milestone. It will allow us to upscale our initiatives and enroll the projects within a larger international platform in the life science airfreight industry. The MoU underlines our vision to foster collaboration with all air cargo stakeholders that support the CEIV pharma industry standard.”
“The IATACEIV Pharma certification program provides participants in the air cargo value chain with the tools and the means to ensure that they are operating to the highest standards for the handling and transport of life saving medicines. This Memorandum of Understanding between Pharma.Aero and IATA formalizes an ongoing collaboration between the two organizations with the aim of better assisting the industry in improving the quality of services for pharmaceutical handling and transport in the air cargo industry worldwide,” said Glyn Hughes IATA’s Global Head of Cargo.
Frank Van Gelder, Secretary General of Pharma.Aero said, “The MOU underlines the mutual benefits for both IATA and Pharma.Aero. The Pharma.Aero members focus on creating content and become a reference to the different pharmaceutical companies and operators within airfreight life science. We are convinced this MOU will boost our initiatives and projects in the pipeline.
Pharma.Aero also hosted its general meeting during the WCS of IATA, with a large group of its members present, representing pharmaceutical shippers, airport communities, airlines, forwarders and handling agents. The status of the ongoing projects was presented and a number of new projects were launched.
